Asepsis announces the patent pending Momenta-Dose™

Asepsis announces the patent pending Momenta-Dose, a parenteral injection device designed to administer an injection solely by a user’s applied force and subsequent momentum. This autogenic momentum injector is industry unique as it does not use any commercial auto-injector technology such as gases, springs or any other stored kinetic energy.

Previous ArticleNext Article